Antibacterial Polypeptide Hydrogel for Stable Wound Infection Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing antibacterial polypeptides, such as J-1, suffer from low antibacterial activity, low bioavailability, and unpredictable toxicity, limiting their clinical applicability and effectiveness against drug-resistant bacteria and fungi.
Innovation Solution
Development of modified antibacterial polypeptide compounds with specific amino acid sequences and their incorporation into hydrogels, which are prepared through ionic crosslinking polymerization, providing enhanced antibacterial activity, stability, and reduced cytotoxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If natural antibacterial polypeptides are used, then safety is improved (less side effects, biodegradable), but antibacterial activity is insufficient and bioavailability is low
Solution Approach 1:
The patent modifies the amino acid sequence parameters of natural polypeptides by introducing specific substitutions (e.g., replacing certain residues with D-amino acids, N-methylated amino acids, or other modified residues) to enhance antibacterial activity while preserving biocompatibility. This parameter optimization resolves the contradiction between natural safety and insufficient activity.
Solution Approach 2:
The patent creates composite polypeptide structures combining multiple modified amino acid types (D-amino acids, N-methylated residues, sulfonated residues) within a single polypeptide chain. This composite approach integrates the benefits of each modification type to achieve both high antibacterial activity and maintained safety profile.
2Reliability
If chemical modification of polypeptide chains is performed to improve antibacterial activity, then activity is enhanced, but toxicity becomes unpredictable
Solution Approach 1:
The patent applies chemical modifications locally at specific positions within the polypeptide chain rather than uniformly across all residues. By targeting specific amino acid positions for modification (e.g., only at hydrophobic or charged residues), the patent enhances activity while controlling toxicity through localized structural changes.
Solution Approach 2:
The patent systematically varies modification parameters (type of amino acid substitution, position of modification, degree of modification) to optimize the activity-toxicity ratio. This controlled parameter adjustment allows prediction and management of toxicity while achieving enhanced antibacterial effects.
3Object-affected harmful factors
If polypeptides are used as hydrogel materials, then biocompatibility is improved (easily hydrolyzed by protease, no adverse effects), but mechanical strength and stability are reduced
Solution Approach 1:
The patent creates composite hydrogel systems where modified polypeptides are combined with crosslinking agents or other biocompatible materials to form a network structure. This composite approach maintains the biodegradability and low toxicity of polypeptides while the crosslinked network provides enhanced mechanical strength and structural stability.
Solution Approach 2:
The patent introduces crosslinking modifications to polypeptide chains before hydrogel formation to pre-establish a stable network structure. This preliminary structural reinforcement ensures adequate mechanical strength is present before the hydrogel is subjected to physiological conditions, while the polypeptide backbone remains susceptible to proteolytic degradation for eventual biocompatible breakdown.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified polypeptides exhibit improved antibacterial and antifungal activity, higher bioavailability, and lower cytotoxicity, effectively treating wounds and preventing infection while promoting healing.
Implementation Method 1
hydrogels which are prepared through ionic crosslinking polymerization
Implementation Method 2
the polypeptide is easily hydrolyzed into amino acids by protease in vivo
Data Source
AI summary
Disclosed by the present invention are an antibacterial polypeptide compound, a medical device, hydrogel and a use thereof. The antibacterial polypeptide compound has high antibacterial activity, high enzymatic hydrolysis stability, high bioavailability and low cytotoxicity. The hydrogel of the present invention does not adhere to wounds, has antibacterial activity and hemostatic properties, and can be used for loading and controlled-release of a drug, for example, an anti-inflammatory drug, an epidermal growth factor, a vascular growth factor or the like may be loaded; moreover, the hydrogel may accelerate healing of the wounds and reduce the formation of scar tissue fibers. In addition, the preparation method of the hydrogel of the present invention involves few processing steps and few types of raw materials and is convenient to perform.